Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lung cancer].

Akira Ono1, Nobuyuki Yamamoto

  • 1Division of Thoracic Oncology, Shizuoka Cancer Center.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 14, 2007
PubMed
Summary
This summary is machine-generated.

Elderly patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) benefit from specific chemotherapy regimens. Ongoing trials aim to optimize treatments for better survival and palliative care in this growing demographic.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic impact of weight loss during first-line chemotherapy in extensive-disease small cell lung cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

M-Sec promotes the production of infectious HIV-1 virus through the exocyst complex in macrophages.

PLoS pathogens·2026
Same author

The gp120 Envelope Glycoprotein of HIV-1 Triggers Macropinocytosis in Primary CD4+ T Cells to Promote HIV-1 Infection.

bioRxiv : the preprint server for biology·2026
Same author

Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study.

Thoracic cancer·2026
Same author

Weight change and impact on prognosis in patients with advanced non-small cell lung cancer with concomitant diabetes mellitus treated with sglt2 inhibitors.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.

Thoracic cancer·2026
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Geriatric Oncology
  • Thoracic Malignancies
  • Clinical Trial Design

Background:

  • The global population is aging, leading to an increased proportion of elderly patients diagnosed with lung cancer.
  • Elderly individuals are often under-represented in clinical trials, necessitating research into suitable treatment regimens.
  • Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are prevalent in the aging population.

Purpose of the Study:

  • To review and evaluate suitable chemotherapy regimens for elderly patients with NSCLC and SCLC.
  • To highlight ongoing and recently conducted clinical trials focusing on geriatric lung cancer patients.
  • To identify effective single-agent and combination chemotherapies for advanced and recurrent lung cancer in the elderly.

Main Methods:

Related Experiment Videos

  • Review of phase II and III clinical trials and subset analyses specifically for elderly lung cancer patients.
  • Examination of single-agent chemotherapies including docetaxel, vinorelbine, CPT-11, gefitinib, TS-1, and Alimta.
  • Analysis of platinum-based chemotherapy regimens and combination chemotherapy for SCLC, such as carboplatin+etoposide.

    • Main Results:

    • Docetaxel and vinorelbine show promise as single agents for advanced NSCLC in the elderly.
    • CPT-11, gefitinib, TS-1, and Alimta are identified as reasonable options for elderly NSCLC patients.
    • Combination chemotherapy (carboplatin+etoposide) is recommended for elderly SCLC patients, with ongoing trials comparing different regimens.

    Conclusions:

    • Optimizing chemotherapy agents and regimens is crucial for improving survival in elderly lung cancer patients.
    • Ongoing clinical trials are essential to establish evidence-based treatment strategies for this demographic.
    • Palliative care should be integrated into treatment plans for elderly patients with lung cancer.